← Eichor
Condition: Oral Cavity Neoplasm Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oral Cavity Neoplasm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279Afatinib in Patients With Fanconi Anemia (FA) and Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase 1/Phase 2 · 2 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT06648096A Trial Evaluating Omission of Radiotherapy to Regional Lymphatic's
Phase 2/Phase 3 · 1 location(s) · All India Institute of Medical Sciences · NCT07528495A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
Phase 1 · 37 location(s) · Aurigene Discovery Technologies Limited · NCT05865002A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Phase 2 · 2 location(s) · Glenn J. Hanna · NCT06805617Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative F
NA · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07124520DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral
NA · 1 location(s) · Anil Chaturvedi · NCT07260344Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O)
NA · 1 location(s) · University Hospital, Montpellier · NCT03545256Mandibular Reconstruction Preplanning (ViPMR)
NA · 1 location(s) · University of British Columbia · NCT05429099A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
Phase 1 · 4 location(s) · MBQ Pharma · NCT06075810Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT03740256Tongue Proactive Strengthening Exercise Program Following Partial/Hemi Glossectomy and Reconstruction
NA · 1 location(s) · Case Comprehensive Cancer Center · NCT07110142Immune Biomarker Study for Salivary Gland Carcinoma
Phase N/A · 2 location(s) · University of Erlangen-Nürnberg Medical School · NCT06047236Spectroscopic Analysis of Tongue Tumor Samples.
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05104619SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Phase N/A · 1 location(s) · University of Palermo · NCT06321003Prevalence and Clinical Implications of HPV Infection in Male IBD Patients
Phase N/A · 1 location(s) · Fundació Institut de Recerca de l'Hospital de la Santa Creu · NCT05911750Sacituzumab Govitecan in Metastatic Salivary Gland and Thyroid Cancers (SG-SGTC)
Phase 2 · 1 location(s) · National University Hospital, Singapore · NCT06923826Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
Phase N/A · 1 location(s) · Stanford University · NCT00568490Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05719779Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral
Phase 4 · 1 location(s) · M.D. Anderson Cancer Center · NCT04265430Determining the Effectiveness of Remote Monitoring of Cancer Patients With Oral Cancer Treatment Using Caaring® Software
NA · 3 location(s) · Persei Vivarium · NCT06998888A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 · 28 location(s) · Jazz Pharmaceuticals · NCT06695845De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06353685Immune Biomarker Study for Head and Neck Cancer
Phase N/A · 3 location(s) · University of Erlangen-Nürnberg Medical School · NCT05375266Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squ
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06448026AI Based Physiotherapy 3- and 9-Month Follow-Up in Oral Cancer Patients
NA · 1 location(s) · National Taiwan University Hospital · NCT07237672Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cance
Phase 2/Phase 3 · 107 location(s) · NRG Oncology · NCT04333537Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the Ex
NA · 4 location(s) · Institut Claudius Regaud · NCT05757817A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Phase 1 · 32 location(s) · Kura Oncology, Inc. · NCT06655246
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.